Sonnet BioTherapeutics Holdings, Inc. Business Combination Communication
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
425
Rhea-AI Filing Summary
Analyzing...
AI-generated analysis. How Rhea-AI works. Not financial advice.
Filed by Sonnet BioTherapeutics Holdings, Inc.
pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934
Subject Company: Sonnet BioTherapeutics Holdings, Inc.
Commission File No. 001-35570
Date: November 18, 2025
